 Wall Street Journal (India) | Bayer challenges compulsory licence issued by India Channel News Asia Over 25,000 patients suffering from liver and kidney cancer die every year in India. Doctors said at least half of them could be saved with timely diagnosis and the help of new cancer drugs. In March this year, India issued its first compulsory license ... Bayer appeals India's ruling on Nexavar generic Stay on cancer drug licence may harm public: Natco Pharma Bayer attempts to block generic Nexavar in India again slammed by MSF |
